This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov-2 | 1327 |
covid-19 | patients | 368 |
clinical | trials | 298 |
clinical | trial | 234 |
- | analysis | 209 |
adverse | effects | 136 |
covid-19 | infection | 133 |
observational | study | 106 |
observational | studies | 96 |
clinical | studies | 94 |
antiviral | effects | 70 |
- | analyses | 68 |
- | risk | 65 |
viral | infections | 65 |
- | cell | 61 |
higher | risk | 56 |
antiviral | drugs | 47 |
severe | disease | 46 |
viral | infection | 41 |
severe | covid-19 | 40 |
- | day | 35 |
antiviral | effect | 34 |
high | risk | 34 |
human | coronavirus | 34 |
several | studies | 34 |
- | effects | 33 |
first | day | 33 |
other | drugs | 33 |
randomized | trial | 33 |
- | treatment | 32 |
significant | effect | 32 |
- | sars | 31 |
immune | cells | 27 |
early | treatment | 25 |
covid-19 | treatment | 25 |
- | hcq | 23 |
- | infection | 20 |
other | studies | 19 |
- | effect | 18 |
therapeutic | effect | 18 |
- | cells | 17 |
- | drug | 17 |
antiviral | drug | 17 |
adverse | effect | 16 |
clinical | study | 16 |
clinical | use | 16 |
effective | treatment | 16 |
low | risk | 16 |
randomized | trials | 15 |
significant | risk | 15 |
respiratory | infections | 15 |
inflammatory | drugs | 15 |
antiviral | treatment | 14 |
effective | treatments | 14 |
potential | risk | 14 |
viral | diseases | 14 |
respiratory | disease | 13 |
therapeutic | effects | 13 |
severe | patients | 13 |
potential | treatment | 13 |
inflammatory | effects | 13 |
covid-19 | treatments | 13 |
cardiac | disease | 12 |
covid-19 | patient | 12 |
randomized | study | 12 |
therapeutic | use | 12 |
respiratory | infection | 11 |
effective | drug | 11 |
randomized | studies | 11 |
- | patients | 11 |
covid-19 | disease | 11 |
- | coronavirus | 11 |
cardiac | risk | 10 |
first | study | 10 |
inflammatory | diseases | 10 |
lower | risk | 10 |
potential | drug | 9 |
therapeutic | drugs | 9 |
other | diseases | 9 |
clinical | effects | 9 |
- | use | 8 |
adverse | drug | 8 |
covid-19 | infections | 8 |
different | cell | 8 |
severe | coronavirus | 8 |
therapeutic | drug | 8 |
potential | drugs | 7 |
viral | effects | 7 |
such | patients | 7 |
other | viruses | 7 |
- | hydroxychloroquine | 7 |
- | chloroquine | 7 |
covid-19 | drugs | 6 |
early | covid-19 | 6 |
higher | hcq | 6 |
human | studies | 6 |
potential | effect | 6 |
potential | risks | 6 |
several | drugs | 6 |
several | risk | 6 |
severe | sars | 6 |
immune | cell | 5 |
several | trials | 5 |
respiratory | viruses | 5 |
potential | treatments | 5 |
inflammatory | effect | 5 |
- | de | 5 |
human | trials | 5 |
different | studies | 5 |
- | covid-19 | 5 |
different | treatment | 5 |
highest | risk | 4 |
significant | effects | 4 |
severe | infections | 4 |
several | days | 4 |
potential | use | 4 |
human | cells | 4 |
severe | infection | 4 |
first | days | 4 |
different | viruses | 4 |
different | drugs | 4 |
acute | infection | 4 |
- | patient | 4 |
early | disease | 4 |
potential | effects | 3 |
other | drug | 3 |
other | risk | 3 |
other | study | 3 |
other | treatments | 3 |
viral | drugs | 3 |
such | treatment | 3 |
viral | disease | 3 |
other | coronavirus | 3 |
viral | y | 3 |
other | covid-19 | 3 |
viral | effect | 3 |
observational | analysis | 3 |
covid-19 | drug | 3 |
acute | covid-19 | 3 |
available | drugs | 3 |
cardiac | diseases | 3 |
clinical | effect | 3 |
human | infection | 3 |
different | disease | 3 |
early | use | 3 |
effective | covid-19 | 3 |
first | trial | 3 |
potential | covid-19 | 2 |
immune | diseases | 2 |
immune | effect | 2 |
inflammatory | disease | 2 |
low | hcq | 2 |
other | cell | 2 |
other | disease | 2 |
other | hcq | 2 |
other | patients | 2 |
other | treatment | 2 |
other | trials | 2 |
several | viruses | 2 |
potential | hydroxychloroquine | 2 |
several | diseases | 2 |
several | drug | 2 |
several | patients | 2 |
human | disease | 2 |
such | study | 2 |
such | treatments | 2 |
therapeutic | treatment | 2 |
therapeutics | used | 2 |
viral | de | 2 |
human | use | 2 |
severe | diseases | 2 |
human | cell | 2 |
different | hcq | 2 |
high | patient | 2 |
- | trial | 2 |
- | viruses | 2 |
acute | use | 2 |
antiviral | treatments | 2 |
available | studies | 2 |
clinical | disease | 2 |
covid-19 | coronavirus | 2 |
covid-19 | study | 2 |
covid-19 | using | 2 |
clinical | treatment | 2 |
different | patient | 2 |
different | treatments | 2 |
high | disease | 2 |
earlier | coronavirus | 2 |
early | drug | 2 |
early | infection | 2 |
early | risk | 2 |
effective | sars | 2 |
different | patients | 2 |
first | used | 2 |
potential | coronavirus | 1 |
other | cq | 1 |
other | infections | 1 |
other | patient | 1 |
respiratory | treatments | 1 |
potential | studies | 1 |
respiratory | treatment | 1 |
respiratory | virus | 1 |
observational | trials | 1 |
other | cells | 1 |
higher | virus | 1 |
lower | hcq | 1 |
lower | drug | 1 |
inflammatory | treatments | 1 |
inflammatory | treatment | 1 |
human | trial | 1 |
human | study | 1 |
human | patients | 1 |
human | patient | 1 |
human | diseases | 1 |
several | cells | 1 |
higher | risks | 1 |
several | cell | 1 |
significant | virus | 1 |
several | disease | 1 |
such | infections | 1 |
higher | drug | 1 |
viral | sars | 1 |
viral | drug | 1 |
viral | cell | 1 |
viral | al | 1 |
therapeutic | trials | 1 |
therapeutic | hcq | 1 |
such | virus | 1 |
such | trials | 1 |
such | effect | 1 |
several | hcq | 1 |
such | drugs | 1 |
such | analysis | 1 |
significant | risks | 1 |
significant | drug | 1 |
significant | analyses | 1 |
severe | patient | 1 |
severe | hydroxychloroquine | 1 |
several | virus | 1 |
several | treatment | 1 |
higher | infection | 1 |
clinical | virus | 1 |
higher | cq | 1 |
higher | chloroquine | 1 |
covid-19 | trials | 1 |
covid-19 | effects | 1 |
clinical | risk | 1 |
clinical | hcq | 1 |
clinical | drug | 1 |
clinical | cell | 1 |
cardiac | effects | 1 |
available | treatment | 1 |
available | hcq | 1 |
antiviral | de | 1 |
antiviral | cq | 1 |
acute | virus | 1 |
acute | treatment | 1 |
acute | cq | 1 |
- | virus | 1 |
- | used | 1 |
- | treatments | 1 |
- | study | 1 |
- | studies | 1 |
- | infections | 1 |
- | days | 1 |
different | cells | 1 |
different | coronavirus | 1 |
different | covid-19 | 1 |
effective | drugs | 1 |
high | risks | 1 |
high | hcq | 1 |
high | cq | 1 |
first | treatment | 1 |
first | studied | 1 |
first | patient | 1 |
first | drugs | 1 |
first | covid-19 | 1 |
effective | hcq | 1 |
early | study | 1 |
different | cq | 1 |
early | studies | 1 |
early | hydroxychloroquine | 1 |
earliest | days | 1 |
earlier | treatment | 1 |
earlier | hcq | 1 |
different | study | 1 |
different | risks | 1 |
different | effects | 1 |
different | drug | 1 |
viral | treatment | 1 |